Sin categoría – Página 18 – SEIOMM, Sociedad Española de Investigación Ósea

Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide.

Calcif Tissue Int. 2018 Nov;103(5):540-545. doi: 10.1007/s00223-018-0450-0. Epub 2018 Jun 27. Reginster JY(1), Hattersley G(2), Williams GC(3), Hu MY(3), Fitzpatrick LA(3), Lewiecki EM(4). DOI: 10.1007/s00223-018-0450-0 -PMCID: PMC6182596 PMID: 29951742 https://www.ncbi.nlm.nih.gov/pubmed/29951742

Serum 25-hydroxyvitamin D levels and incident falls in older women.

Osteoporos Int. 2018 Sep 25. doi: 10.1007/s00198-018-4705-4. DOI: 10.1007/s00198-018-4705-4 -PMID: 30255229 Uusi-Rasi K(1), Patil R(2)(3), Karinkanta S(2), Tokola K(2), Kannus P(2)(4)(5), Lamberg-Allardt C(6), Sievänen H(2).

Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray-Based Bone Assessment Techniques.

J Bone Miner Res. 2018 Aug 13. doi: 10.1002/jbmr.3565. DOI: 10.1002/jbmr.3565 -PMID: 30102789 Paschalis EP(1), Krege JH(2), Gamsjaeger S(1), Eriksen EF(3), Burr DB(4), Disch DP(2), Stepan JJ(5), Fahrleitner-Pammer A(6), Klaushofer K(1), Marin F(2), PavoI(2). https://www.ncbi.nlm.nih.gov/pubmed/30102789

Associations between sedentary time, physical activity and bone health among older people using compositional data analysis.

PLoS One. 2018 Oct 22;13(10):e0206013. doi: 10.1371/journal.pone.0206013.eCollection 2018. Rodríguez-Gómez I, Mañas A, Losa-Reyna J, Rodríguez-Mañas L, Chastin SFM, Alegre LM, García-García FJ, Ara I.

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Osteoporos Int. 2018 Sep 22. doi: 10.1007/s00198-018-4687-2. Kendler DL, Chines A, Brandi ML, Papapoulos S, Lewiecki EM, Reginster JY, Muñoz Torres M, Wang A, Bone HG..

Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden.

J Bone Miner Res. 2018 Nov 29. doi: 10.1002/jbmr.3602. [Epub ahead of print] de Castro LF(1), Burke AB(1)(2), Wang HD(1)(3), Tsai J(1)(2), Florenzano P(1)(4), Pan KS(1)(3), Bhattacharyya N(1), Boyce AM(1), Gafni RI(1), Molinolo AA(5), Robey … Leer más

In situ gel-forming system for dual BMP-2 and 17β-estradiol controlled release for bone regeneration in osteoporotic rats.

Drug Deliv Transl Res. 2018 Oct;8(5):1103-1113. doi:10.1007/s13346-018-0574-9. Segredo-Morales E, Reyes R, Arnau MR, Delgado A, Évora C. https://www.ncbi.nlm.nih.gov/pubmed/30105738

Impact of prescription drugs on second fragility fractures among US Medicare patients.

Osteoporos Int. 2018 Sep 19. doi: 10.1007/s00198-018-4697-0. DOI: 10.1007/s00198-018-4697-0 PMID: 30232537 Munson JC(1)(2)(3), Bynum JPW(4)(5)(6)(7), Bell JE(4)(8), McDonough C(9), Wang Q(4), Tosteson T(4)(10), Tosteson ANA(4)(5). https://www.ncbi.nlm.nih.gov/pubmed/30232537

Characteristics of Self-Reported Sleep and the Risk of Falls and Fractures: The Women’s Health Initiative (WHI).

J Bone Miner Res. 2018 Nov 21. doi: 10.1002/jbmr.3619. Cauley JA(1), Hovey KM(2), Stone KL(3)(4), Andrews CA(5), Barbour KE(6), Hale L(7)(8), Jackson RD(9), Johnson KC(10), LeBlanc ES(11), Li W(12), Zaslavsky O(13), Ochs-Balcom H(2), Wactawski-Wende J(2), … Leer más

Nutritional deficiencies and bone metabolism after endobarrier in obese type 2 patients with diabetes.

Eur J Clin Nutr. 2018 Oct;72(10):1447-1450. doi:10.1038/s41430-017-0074-x. Vilarrasa N, Fabregat A, Toro S, Gordejuela AG, Casajoana A, Montserrat M, Garrido P, López-Urdiales R, Virgili N, Planas-Vilaseca A, Simó-Servat A, Pujol J.